Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 25/3/20251 min de lectura
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
Traducción automática local · Idioma original de la fuente
Resumen
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →